ARTICLE | Emerging Company Profile
Kymera: a systematic approach to protein degradation
Kymera goes beyond empirical approach to protein degradation with Pegasus platform
July 3, 2019 3:53 PM UTC
With a computational drug discovery platform and a proprietary library of E3 ligases and binders, Kymera believes it can accelerate the discovery and development of protein degraders.
Protein degradation is entering the mainstream as a new modality that can direct medicines at proteins often seen as "undruggable,” such as transcription factors, scaffolds in protein complexes and signaling adaptor molecules...
BCIQ Company Profiles